U.S. Markets closed


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.0000.000 (0.000%)
Full screen
Previous Close0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals9 months ago

    ​FDA approves Cambridge-based Vericel's knee cartilage repair product

    Shares of Cambridge-based Vericel surged late Tuesday after the FDA approved a treatment for knee cartilage repair that involves harvesting a patient’s own cells. The FDA said it had approved Vericel's Maci, a product that collects and expands a patient’s cells — called autologous cells — then places them onto a collagen membrane that is implanted over the area where tissue was removed. Vericel has two other FDA-approved products, skin graft treatment Epicel and another knee cartilage repair product called Carticel.

  • We're sorry this is all we were able to find about this topic.